| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2606 | Tadalafil | RAKSHIT PHARMACEUTICALS LIMITED Anakapalli District IN | 100039283;100061839 | CEP 2016-317 - Rev 01 | 2025/05/27 | Valid | Chemical | 2025/05/27 | Minor revision|CEP granted|27/05/2025; Renewal|CEP granted|17/08/2023; Notification|CEP granted|11/01/2023; Minor revision|Accepted - CEP remains valid|13/04/2021 |
||
| 2182 | Trimebutine maleate | MOEHS IBERICA S.L. Rubi ES | 100029092;100068825 | CEP 2011-170 - Rev 02 | 2025/05/27 | Valid | Chemical | 2025/05/27 | Minor revision|CEP granted|27/05/2025 | ||
| 2445 | Adapalene, Micronised and non-micronised | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 2022-259 - Rev 02 | 2025/05/27 | Valid | 28/07/2028 | Chemical | 2025/05/27 | Administrative procedure|CEP granted|27/05/2025; Minor revision|CEP granted|25/04/2025; New application|CEP granted|28/07/2023 |
|
| 2101 | Tetryzoline hydrochloride | PCAS Ecully FR | 100011754;100054740 | CEP 2019-180 - Rev 01 | 2025/05/27 | Valid | 28/09/2026 | Chemical | 2025/05/27 | Minor revision|CEP granted|27/05/2025 | |
| 1551 | Nomegestrol acetate | INDUSTRIALE CHIMICA S.R.L. Saronno IT | 100011692;100020331 | CEP 2019-038 - Rev 02 | 2025/05/27 | Valid | Chemical | 2025/05/27 | Renewal|CEP granted|27/05/2025; Notification|Accepted - CEP remains valid|13/06/2023; Notification|Rejected|17/05/2023; Minor revision|CEP granted|01/04/2021 |
||
| 1270 | Terconazole | NOSCH LABS PRIVATE LIMITED Hyderabad IN | 100020550;100029297 | CEP 2022-298 - Rev 01 | 2025/05/27 | Valid | 13/11/2029 | Chemical | 2025/05/27 | Minor revision|CEP granted|27/05/2025; New application|CEP granted|13/11/2024 |
|
| 2765 | Eplerenone | ZHEJIANG ACINOVA PHARMACEUTICAL CO., LTD. Taizhou CN | 100054484;100096546 | CEP 2017-276 - Rev 03 | 2025/05/27 | Valid | Chemical | 2025/05/27 | Notification|CEP granted|27/05/2025; Renewal|CEP granted|27/05/2024; Minor revision|CEP granted|09/07/2021 |
||
| 388 | Dexamethasone | BHAGERIA & JAJODIA PHARMACEUTICALS PRIVATE LIMITED Vapi IN | 100050824;100088833 | CEP 2024-138 - Rev 00 | 2025/05/27 | Valid | 27/05/2030 | Chemical | 2025/05/27 | New application|CEP granted|27/05/2025 | |
| 2372 | Esomeprazole magnesium trihydrate, Micronised | SMILAX LABORATORIES LIMITED Hyderabad IN | 100011578;100021649 | CEP 2024-277 - Rev 00 | 2025/05/27 | Valid | 27/05/2030 | Chemical | 2025/05/27 | New application|CEP granted|27/05/2025 | |
| 1765 | Salmeterol xinafoate | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2011-277 - Rev 04 | 2025/05/26 | Valid | Chemical | 2025/08/11 | Minor revision|Accepted - CEP remains valid|11/08/2025; Notification|CEP granted|26/05/2025; Minor revision|CEP granted|12/09/2023; Notification|CEP granted|07/09/2021 |
||
| 1368 | Ramipril | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2003-219 - Rev 08 | 2025/05/26 | Valid | Chemical | 2025/05/26 | Notification|CEP granted|26/05/2025; Minor revision|Accepted - CEP remains valid|05/03/2024; Notification|CEP granted|16/12/2022; Minor revision|Accepted - CEP remains valid|14/11/2022 |
||
| 687 | Salbutamol sulfate | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2000-143 - Rev 08 | 2025/05/26 | Valid | Chemical | 2025/09/05 | Minor revision|Accepted - CEP remains valid|05/09/2025; Notification|CEP granted|26/05/2025; Monograph revision|Accepted - CEP remains valid|26/03/2024; Major revision|CEP granted|15/03/2022 |
||
| 2258 | Olanzapine, Form-1 | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2012-190 - Rev 02 | 2025/05/26 | Valid | Chemical | 2025/05/26 | Notification|CEP granted|26/05/2025; Minor revision|Accepted - CEP remains valid|07/09/2022; Notification|CEP granted|07/09/2021 |
||
| 2535 | Levetiracetam | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2011-380 - Rev 08 | 2025/05/26 | Valid | Chemical | 2026/02/05 | Minor revision|Accepted - CEP remains valid|05/02/2026; Minor revision|Accepted - CEP remains valid|21/08/2025; Notification|CEP granted|26/05/2025; Minor revision|CEP granted|02/08/2024; Administrative procedure|CEP granted|29/06/2023; Minor revision|CEP granted|15/06/2023; Minor revision|CEP granted|07/02/2022; Minor revision|Accepted - CEP remains valid|04/08/2021; Minor revision|Accepted - CEP remains valid|16/02/2021; Minor revision|Accepted - CEP remains valid|07/05/2020 |
||
| 2359 | Dorzolamide hydrochloride | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2008-155 - Rev 04 | 2025/05/26 | Valid | Chemical | 2025/11/19 | Minor revision|Accepted - CEP remains valid|19/11/2025; Notification|CEP granted|26/05/2025; Minor revision|Accepted - CEP remains valid|25/10/2024; Minor revision|Accepted - CEP remains valid|24/01/2023; Notification|CEP granted|07/09/2021; Minor revision|Accepted - CEP remains valid|26/02/2021 |
||
| 2306 | Gemcitabine hydrochloride, Process III | INTAS PHARMACEUTICALS LIMITED Ahmedabad IN | 100011529;100023432 | CEP 2022-092 - Rev 02 | 2025/05/26 | Valid | 13/07/2027 | Chemical | 2025/05/26 | Minor revision|CEP granted|26/05/2025; Minor revision|CEP granted|02/09/2024; Minor revision|Accepted - CEP remains valid|07/11/2023; Notification|Rejected|08/09/2023; New application|CEP granted|13/07/2022 |
|
| 2733 | Escitalopram oxalate, Process-III | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2021-161 - Rev 03 | 2025/05/26 | Valid | 27/07/2026 | Chemical | 2025/05/26 | Minor revision|CEP granted|26/05/2025; Minor revision|CEP granted|22/08/2024; Minor revision|Accepted - CEP remains valid|06/03/2024; Minor revision|CEP granted|07/08/2023; Minor revision|Accepted - CEP remains valid|02/02/2022; New application|CEP granted|27/07/2021 |
|
| 2932 | Rivaroxaban, Micronised | MOEHS IBERICA S.L. Rubi ES | 100029092;100068825 | CEP 2021-245 - Rev 02 | 2025/05/26 | Valid | 27/06/2028 | Chemical | 2025/05/26 | Minor revision|CEP granted|26/05/2025; Minor revision|CEP granted|07/09/2023; New application|CEP granted|27/06/2023 |
|
| 2604 | Ropinirole hydrochloride, Form-I | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2017-219 - Rev 04 | 2025/05/26 | Valid | Chemical | 2026/02/02 | Minor revision|Accepted - CEP remains valid|02/02/2026; Minor revision|Accepted - CEP remains valid|23/09/2025; Notification|CEP granted|26/05/2025; Renewal|CEP granted|19/11/2024; Minor revision|CEP granted|17/01/2023; Minor revision|CEP granted|07/03/2022 |
||
| 2359 | Dorzolamide hydrochloride, Process II | NEULAND LABORATORIES LIMITED Hyderabad IN | 100011545;100062134 | CEP 2017-089 - Rev 01 | 2025/05/26 | Valid | Chemical | 2025/05/26 | Notification|CEP granted|26/05/2025; Minor revision|Accepted - CEP remains valid|24/02/2025; Minor revision|Accepted - CEP remains valid|06/08/2024; Renewal|CEP granted|22/08/2022; Notification|CEP granted|16/09/2021; Minor revision|Accepted - CEP remains valid|26/02/2021 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号